Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro.
Hideaki NishiharaSasha SoldatiAdrien MossuMaria RositoHenriette RudolphWilliam A MullerDaniela LatorreFederica SallustoMireia SospedraRoland MartinHiroshi IshikawaTobias TenenbaumHorst SchrotenFabien GosseletBritta EngelhardtPublished in: Fluids and barriers of the CNS (2020)
Our observations underscore that different Th subsets may use different anatomical routes to enter the CNS during immune surveillance versus neuroinflammation with the BCSFB establishing a tighter barrier for T-cell entry into the CNS compared to the BBB. In addition, CNS-entry experienced Th cell subsets isolated from the CSF of MS patients do not show an increased ability to cross the brain barriers when compared to circulating Th cell subsets from healthy donors underscoring the active role of the brain barriers in controlling T-cell entry into the CNS. Also we identify ICAM-1 to mediate T cell migration across the BCSFB.
Keyphrases
- blood brain barrier
- cerebral ischemia
- cell migration
- peripheral blood
- resting state
- white matter
- endothelial cells
- single cell
- cell therapy
- functional connectivity
- end stage renal disease
- multiple sclerosis
- ejection fraction
- newly diagnosed
- mass spectrometry
- prognostic factors
- traumatic brain injury
- stem cells
- ms ms
- mesenchymal stem cells
- lipopolysaccharide induced
- bone marrow
- subarachnoid hemorrhage
- brain injury
- induced pluripotent stem cells